Skip to main content

Table 6 Levels and reducing percentage of LDL-C, dosage and duration in different statin group

From: Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound

Group

N

Age

MeanLDL-C at Baseline (mg)

MeanLDL-C at Follow up (mg)

Mean Reducing percentage

Statin dosage (mg)

Duration (month)

Rosuvastatin

1173

58.1±1.8

123.9±8.6

63.3±7.4

48.4±4.2

33.3±11.6

20.5±6.3

Atorvastatin

1138

58.4±2.5

128.0±14.0

73.0±8.7

42.3±3.7

60.3±28.6

17.5±7.1

Pitavastatin

125

62.5±11.5

130.9±33.3

81.1±23.4

36.2±19.5

4

8~12

Fluvastatin

40

63.0±10.0

144.9±31.5

98.1±12.7

32.3

60

12

Simvastatin

90

57.9±0.1

136.61±5.3

81.2±3.5

39.9±6.1

28.9±10.0

17.8±6.5

Pravastatin

319

58.2±3.2

146.8±7.4

108.9±2.9

24.6±2.6

34.8±9.9

15.4±5.0